A growth hormone trial had issues with its readout, including being open-label and relying on epigenetic clocks.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.